Intraductal papillary mucinous carcinoma with co-mutations of KRAS/STK11

BMJ Case Rep. 2023 Nov 27;16(11):e255945. doi: 10.1136/bcr-2023-255945.

Authors

Munemasa Nagao^{1

2}, Taro Ueo², Akihisa Fukuda³, Masaya Ohana²

Affiliations

¹ Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine Faculty of Medicine, Kyoto, kyoto, Japan ds110559@kuhp.kyoto-u.ac.jp.
² Department of Gastroenterology and Hepatology, Tenri Hospital, Tenri, Nara, Japan.
³ Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine Faculty of Medicine, Kyoto, kyoto, Japan.

PMID: 38011945
PMCID: PMC10685908 (available on 2025-11-27)
DOI: 10.1136/bcr-2023-255945

No abstract available

Keywords: Gastroenterology; Genetics; Pancreas and biliary tract.

Publication types

Case Reports

MeSH terms

AMP-Activated Protein Kinase Kinases
Adenocarcinoma, Mucinous* / genetics
Adenocarcinoma, Mucinous* / pathology
Adenocarcinoma, Papillary* / pathology
Carcinoma, Pancreatic Ductal* / genetics
Humans
Mutation
Pancreatic Neoplasms* / genetics
Pancreatic Neoplasms* / pathology
Proto-Oncogene Proteins p21(ras) / genetics

Substances

Proto-Oncogene Proteins p21(ras)
KRAS protein, human
STK11 protein, human
AMP-Activated Protein Kinase Kinases